Effect of tesaglitazar, a dual PPARα/γ agonist, on glucose and lipid abnormalities in patients with type 2 diabetes: a 12-week dose-ranging trial

By Goldstein Barry J.   Rosenstock Julio   Anzalone Deborah   Tou Conrad   Öhman K. Peter  

Current Medical Research and Opinion, Vol. 22, Iss. 12, 2006-12 ,pp. : 2575-2590

Informa Healthcare

Access to resources Recommend Favorite

Effect of obesity and type 2 diabetes, and glucose ingestion on circulating spexin concentration in adolescents

By  

PEDIATRIC DIABETES (ELECTRONIC), Vol. 19, Iss. 2, 2018-03 ,pp. : 212-216

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treatment with marine collagen peptides modulates glucose and lipid metabolism in Chinese patients with type 2 diabetes mellitus

By Zhu Cui-Feng   Li Guan-Zhi   Peng Hong-Bin   Zhang Fan   Chen Yun   Li Yong  

Applied Physiology, Nutrition, and Metabolism, Vol. 35, Iss. 6, 2010-12 ,pp. : 797-804

NRC Research Press

Access to resources Recommend Favorite

Quantifying the effect of exenatide and insulin glargine on postprandial glucose excursions in patients with type 2 diabetes

By Brodows Robert G.   Qu Yongming   Johns Don   Kim Dennis   Holcombe John H.  

Current Medical Research and Opinion, Vol. 24, Iss. 5, 2008-05 ,pp. : 1395-1397

Informa Healthcare

Access to resources Recommend Favorite

An investigation and comparison of the effectiveness of different exercise programmes in improving glucose metabolism and pancreatic β cell function of type 2 diabetes patients

By  

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (ELECTRONIC), Vol. 1368-5031, Iss. 10, 2015-10 ,pp. : 1159-1170

John Wiley & Sons Inc

Access to resources Recommend Favorite